Remus Pharmaceuticals IPO — Listing Performance
Remus Pharmaceuticals IPO facts & figures
| Issue category | SME |
|---|---|
| Issue open date | 17 May 2023 |
| Listing date | 29 May 2023 |
| Issue price | ₹1,229 |
| Listing-day close | ₹1,796.80 (46.2%) |
| Recent market price | ₹880 (-28.4% vs issue) |
| 52-week range | ₹582.85 – ₹4,475 |
| Identifiers | NSE: REMUS · ISIN: INE0O5T01011 |
How the listing went
Remus Pharmaceuticals had a strong market debut, ending listing day 46.2% over the issue price.
Remus Pharmaceuticals against every other debut on record
- Rank in 2023: 55 of 172 NSE debuts, on a 46.2% first-day close.
- 65th percentile of 116 SME debuts in 2023 (median 20.72%).
- 4th of 6 debuts in May 2023.
- Opened 39.24% above issue, then added 6.96 points to the close.
- Day-one range ₹1,711.25 to ₹1,796.80: a 6.96% swing on the issue price.
- Last close ₹880 (11 Sep 2026): 28.4% below issue, against 46.2% on day one.
- 8% up its 52-week range of ₹582.85 to ₹4,475.
- Priced at the top of the ₹1,150 to ₹1,229 band.
- Listed 10 calendar days after close.
- All 601 SME debuts on record: median 14.22%, 79% closed above issue.
Computed over 1109 verified NSE debuts to 11 Sep 2026 · sources